Aurobindo Pharma Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

15 Apr 2021 | 04:00 PM

914.65
4.90 (0.54%)

  • Outperforms Index

    77.65%

    Return (1Y)

    Beaten S&P BSE Healthcare by 26%

  • More Volatile

    2.54%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.29%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

52 Week High-Low

1,023

1,023.10

464

464.35

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Aurobindo Pharma Ltd has increased by 8.57% since past 3 Months

  • MF shareholding in Aurobindo Pharma Ltd has decreased by -9.8% since past 3 Months

  • FII shareholding in Aurobindo Pharma Ltd has increased by 16.63% since past 1 Year

  • MF shareholding in Aurobindo Pharma Ltd has decreased by -22.18% since past 1 Year

Loading...